YMRC
Yorktown Management & Research Company’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,350
| Closed | -$466K | – | 248 |
|
|
2020
Q4 | $466K | Buy |
4,350
+580
| +15% | +$62.1K | 0.42% | 91 |
|
|
2020
Q3 | $330K | Buy |
3,770
+220
| +6% | +$19.3K | 0.31% | 170 |
|
|
2020
Q2 | $349K | Sell |
3,550
-7,750
| -69% | -$762K | 0.31% | 102 |
|
|
2020
Q1 | $861K | Sell |
11,300
-7,150
| -39% | -$545K | 0.87% | 7 |
|
|
2019
Q4 | $1.63M | Buy |
18,450
+1,450
| +9% | +$128K | 0.88% | 7 |
|
|
2019
Q3 | $1.29M | Hold |
17,000
| – | – | 0.69% | 12 |
|
|
2019
Q2 | $1.24M | Hold |
17,000
| – | – | 0.47% | 45 |
|
|
2019
Q1 | $1.37M | Hold |
17,000
| – | – | 0.44% | 49 |
|
|
2018
Q4 | $1.57M | Sell |
17,000
-2,800
| -14% | -$258K | 0.52% | 48 |
|
|
2018
Q3 | $1.87M | Buy |
19,800
+2,000
| +11% | +$189K | 0.55% | 46 |
|
|
2018
Q2 | $1.65M | Hold |
17,800
| – | – | 0.48% | 47 |
|
|
2018
Q1 | $1.69M | Sell |
17,800
-1,400
| -7% | -$133K | 0.5% | 45 |
|
|
2017
Q4 | $1.86M | Buy |
19,200
+15,000
| +357% | +$1.45M | 0.54% | 40 |
|
|
2017
Q3 | $373K | Buy |
+4,200
| New | +$373K | 0.1% | 143 |
|
|
2016
Q1 | – | Sell |
-56,900
| Closed | -$3.37M | – | 361 |
|
|
2015
Q4 | $3.37M | Buy |
56,900
+1,900
| +3% | +$113K | 0.6% | 44 |
|
|
2015
Q3 | $2.99M | Buy |
55,000
+15,000
| +38% | +$816K | 0.5% | 57 |
|
|
2015
Q2 | $2.69M | Buy |
40,000
+20,000
| +100% | +$1.34M | 0.47% | 63 |
|
|
2015
Q1 | $1.17M | Buy |
+20,000
| New | +$1.17M | 0.21% | 104 |
|